The Inquirer and Jefferson Univ. Corporate Suite is Pushing President Out for Questioning “The Science”

After demonstrating new lows in journalism this past Sunday with a front-page headline condemning Jefferson University President Mark L. Tykocinski for liking tweets about currently debated scientific subject matter, the Inquirer has shown it won’t quit until Tykocinski is removed. In today’s paper the Iquirer brought on CEO of Jefferson, Joseph G. Cacchione, to make the coup de grâce and save taboo scientific subjects like vaccine safety and sex change surgeries for children from any attempts at closer scrutiny.

Jessa Lingel, an associate professor of communication and gender, sexuality, and women’s studies at the University of Pennsylvania, was picked to help gaslight the public about Tykocinski’s response to being asked by The Inquirer if he thought transgender surgery was “child mutilation.” Lingel said: “You shouldn’t need specialized understanding in pediatric care to recognize that trans-affirming care is simply part of health care and part of well-being.” “It’s not a radical stance to say that trans-affirming care is not mutilation for children or anybody.”

Removal of a child’s sexual organs is most certainly a controversial subject worthy of debate and an exchange of ideas.  One might recall the significant coverage and outrage several years ago concerning the religious practices in certain North Eastern African nations that involve what was broadly called in the media “female genital mutilation”.

One of the tweets by Pres. Tykocinski being condemned for “liking.”

We are seeing, before our eyes, the establishment of a tyranny built on the foundations of public health. This Establishment appears to be in a tense and itchy trigger finger moment where any rays of light that might appear from a pulled-back curtain are quickly and efficiently extinguished.

Consider the other top-offending “likes” Tykocinski is being shouted down for. Berenson pointed out only the most obvious unofficial facts about the mRNA shots: weak long-term efficacy, lousy side effects, and the dangers of regulatory capture by Pharma. These clear and easy-to-swallow truths must not make their way into the mainstream, or the whole system of sick care may be put in jeopardy.